Skip to main content

Denali Therapeutics Inc.

DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001714899

In the last 90 days, Denali Therapeutics Inc. insiders filed 0 open-market purchases and 3 sales; 285 institutions reported holding it in 13F filings for Q3 2026, worth $3.15B in total; no superinvestor holds it.

Holders of 5% or more of DNLI

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Denali Therapeutics Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of DNLI
HolderLatest formStakeChangeFirst filedLatest filingFiling
T. Rowe Price Investment Management, Inc.13G/A12.30%19.6M shares+2.10 ppfrom 10.20%May 15, 20263 filingsNov 16, 2026SEC
Baillie Gifford & Co13G/A7.50%12.0M shares−1.10 ppfrom 8.60%Jan 12, 20216 filingsAug 4, 2026SEC
BlackRock, Inc.13G/A7.20%10.5M shares–Oct 21, 20243 filingsApr 17, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

46 Schedule 13D and 13G filings on Denali Therapeutics Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on DNLI
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 16, 202610:02 AM ETT. Rowe Price Investment Management, Inc.13G/A12.30%19.6M shares+2.10 ppfrom 10.20%Sep 30, 2026SEC
Aug 4, 20269:11 AM ETBaillie Gifford & Co13G/A7.50%12.0M shares−1.10 ppfrom 8.60%Jun 30, 2026SEC
Jul 8, 202611:30 AM ETT. Rowe Price Investment Management, Inc.13G/A10.20%16.2M shares+4.80 ppfrom 5.40%Jun 30, 2026SEC
May 15, 202610:06 AM ETT. Rowe Price Investment Management, Inc.13G5.40%8.52M sharesNewMar 31, 2026SEC
May 6, 202611:13 AM ETFMR LLCand 1 other13G/A4.20%6.67M shares−1.60 ppfrom 5.80%Below 5%Mar 31, 2026SEC
Mar 26, 20266:06 PM ETVanguard Group Inc13G/A0.00%0 shares–Below 5%Mar 13, 2026SEC
Nov 5, 202511:30 AM ETFMR LLCand 1 other13G/A5.80%8.54M shares–Sep 30, 2025SEC
Aug 12, 202510:34 AM ETWellington Management Group LLPand 2 others13G/A3.90%5.66M shares–Below 5%Jun 30, 2025SEC
Apr 17, 20253:05 PM ETBlackRock, Inc.13G/A7.20%10.5M shares–Mar 31, 2025SEC
Feb 13, 20252:14 PM ETCapital Research Global Investors13G/A3.80%5.48M shares–Below 5%Dec 31, 2024SEC
Feb 12, 202510:52 AM ETBaillie Gifford & Co13G/A8.60%12.3M shares–Dec 31, 2024SEC
Nov 12, 2024Capital Research Global Investors13GOld format–New–SEC
Nov 12, 2024FMR LLC13G/AOld format–––SEC
Nov 8, 2024BlackRock, Inc.13G/AOld format–––SEC
Nov 8, 2024Wellington Management Group LLP13G/AOld format–––SEC
Nov 7, 20244:48 PM ETBiogen Inc.13G/AOld format–––SEC
Oct 21, 2024BlackRock, Inc.13G/AOld format–––SEC
Aug 16, 2024FMR LLC13GOld format–––SEC
Feb 13, 2024Vanguard Group Inc13G/AOld format–––SEC
Feb 13, 2024Bratton Douglas K13G/AOld format–––SEC
Feb 12, 20247:07 PM ETBiogen Inc.13G/AOld format–––SEC
Feb 8, 2024Wellington Management Group LLP13GOld format–New–SEC
Jan 30, 2024Temasek Holdings (Private) Ltd13G/AOld format–––SEC
Jan 30, 2024Baillie Gifford & Co13G/AOld format–––SEC
Jan 25, 20244:59 PM ETBlackRock Inc.13G/AOld format–––SEC
Mar 30, 2023Temasek Holdings (Private) Ltd13GOld format–New–SEC
Feb 13, 2023Bratton Douglas K13G/AOld format–––SEC
Feb 9, 2023Vanguard Group Inc13G/AOld format–––SEC
Feb 9, 2023FMR LLC13G/AOld format–––SEC
Jan 31, 20235:52 PM ETBlackRock Inc.13G/AOld format–––SEC
Jan 20, 2023Baillie Gifford & Co13G/AOld format–––SEC
Feb 14, 2022Bratton Douglas K13G/AOld format–––SEC
Feb 14, 2022Price T Rowe Associates Inc13G/AOld format–––SEC
Feb 9, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 9, 2022FMR LLC13G/AOld format–––SEC
Feb 8, 2022ARCH Venture Fund VIII, L.P.13G/AOld format–––SEC
Feb 3, 20224:41 PM ETBlackRock Inc.13G/AOld format–––SEC
Jan 18, 2022Baillie Gifford & Co13G/AOld format–––SEC
Feb 16, 2021Flagship Ventures Fund V, L.P.13G/AOld format–––SEC
Feb 16, 2021Price T Rowe Associates Inc13GOld format–New–SEC
Feb 12, 2021Bratton Douglas K13G/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13G/AOld format–––SEC
Feb 8, 2021FMR LLC13G/AOld format–––SEC
Feb 2, 20212:56 PM ETBlackRock Inc.13GOld format–New–SEC
Feb 2, 2021ARCH Venture Fund VIII, L.P.13G/AOld format–––SEC
Jan 12, 2021Baillie Gifford & Co13G/AOld format–––SEC

Form 144: proposed insider sales

78 notices from officers, directors and other affiliates planning to sell Denali Therapeutics Inc. shares, newest first.

Form 144 notices for DNLI
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Sep 4, 20268:38 PM ETChin Peter ScottOfficer1.65K$36.9KSep 4, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Sep 2, 20264:31 PM ETNancy ThornberryDirector11.4K$266.1KSep 2, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Sep 1, 20264:47 PM ETAlexander SchuthOfficer2.77K$65.8KSep 1, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 11, 20265:39 PM ETSchuth Alexander O.Officer2.86K$71.6KAug 11, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Feb 5, 20264:14 PM ETCarole HoFormer affiliate39.5K$801.4KFeb 5, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Feb 4, 20264:16 PM ETCarole HoFormer affiliate150.0K$3.18MFeb 4, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Feb 3, 20264:47 PM ETCarole HoFormer affiliate150.0K$3.32MFeb 3, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 6, 20268:28 PM ETHo CaroleConsultant17.2K$284.1KJan 6, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 6, 20268:25 PM ETSchuth Alexander O.Officer17.2K$284.1KJan 6, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 6, 20268:24 PM ETWatts Ryan J.Director · Officer35.2K$580.8KJan 6, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Dec 4, 20254:41 PM ETCarole HoOfficer1.88K$35.8KDec 4, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 13, 20254:45 PM ETCarole HoOfficer806$10.7KAug 13, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 12, 20258:46 PM ETSchuth Alexander O.Officer2.94K$39.9KAug 12, 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 12, 20258:44 PM ETHo CaroleOfficer2.94K$39.9KAug 12, 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jul 9, 20254:13 PM ETWatts Ryan J.Officer495.3K$7.10MJul 9, 202510b5-1Jefferies LLCSEC
Jan 7, 20258:14 PM ETHo CaroleOfficer2.91K$60.5KJan 7, 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 7, 20258:12 PM ETSchuth Alexander O.Officer2.91K$60.5KJan 7, 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 7, 20258:10 PM ETWatts Ryan J.Director · Officer7.65K$159.2KJan 7, 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 7, 20258:08 PM ETKrognes Steve E.Director3.34K$69.5KJan 7, 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 7, 20258:06 PM ETSchuth Alexander O.Officer12.3K$247.8KJan 6, 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 7, 20258:03 PM ETWatts Ryan J.Director · Officer29.3K$591.7KJan 6, 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 7, 20258:01 PM ETHo CaroleOfficer12.3K$247.8KJan 6, 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 2, 20254:23 PM ETVicki Lee SatoDirector6.16K$125.5KJan 2, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Dec 31, 20244:17 PM ETSteve KrognesDirector30.0K$607.2KDec 31, 202410b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Nov 12, 20247:47 AM ETDavid SchenkeinDirector59.4K$1.86MNov 11, 202410b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC

Showing the latest 25. See the DNLI notices from the last 12 months